Zacks Investment Research upgraded shares of PSS WORLD MED (PSSI) from UNDERPERFORM to NEUTRAL on July 10, 2012, with a target price of $22.40.
PSS World Medical, Inc. is a specialty marketer and distributor of medical products to physicians, alternate-site imaging centers, long-term care providers, home care providers, and hospitals. They have become a leader in three of the market segments it serves with a focused, market specific approach to customer service, a consultative sales force, strategic acquisitions, strong arrangements with product manufacturers, innovative systems, and a unique culture of performance.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on PSS WORLD MED (PSSI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment